{"abstract": "How AbbVie came to win Shire demonstrates that even in the middle of a new boom in mergers and acquisitions, a hefty premium is no guarantee of success.", "web_url": "https://dealbook.nytimes.com/2014/07/24/to-woo-shire-abbvie-trod-cautiously-in-takeover-bid/", "snippet": "How AbbVie came to win Shire demonstrates that even in the middle of a new boom in mergers and acquisitions, a hefty premium is no guarantee of success.", "lead_paragraph": "Susan Kilsby had not been chairwoman of the drug maker Shire for even a week when she received an office call that would set off a frenzied trans-Atlantic courtship.", "print_section": "B", "print_page": "6", "source": "The New York Times", "multimedia": [{"rank": 0, "subtype": "xlarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/25/business/Drug/Drug-articleLarge.jpg", "height": 394, "width": 600, "subType": "xlarge", "crop_name": "articleLarge", "legacy": {"xlarge": "images/2014/07/25/business/Drug/Drug-articleLarge.jpg", "xlargewidth": 600, "xlargeheight": 394}}, {"rank": 0, "subtype": "jumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/25/business/Drug/Drug-jumbo.jpg", "height": 673, "width": 1024, "subType": "jumbo", "crop_name": "jumbo", "legacy": {}}, {"rank": 0, "subtype": "superJumbo", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/25/business/Drug/Drug-superJumbo.jpg", "height": 1345, "width": 2048, "subType": "superJumbo", "crop_name": "superJumbo", "legacy": {}}, {"rank": 0, "subtype": "thumbnail", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/25/business/Drug/Drug-thumbStandard-v2.jpg", "height": 75, "width": 75, "subType": "thumbnail", "crop_name": "thumbStandard", "legacy": {"thumbnail": "images/2014/07/25/business/Drug/Drug-thumbStandard-v2.jpg", "thumbnailwidth": 75, "thumbnailheight": 75}}, {"rank": 0, "subtype": "thumbLarge", "caption": null, "credit": null, "type": "image", "url": "images/2014/07/25/business/Drug/Drug-thumbLarge-v2.jpg", "height": 150, "width": 150, "subType": "thumbLarge", "crop_name": "thumbLarge", "legacy": {}}], "headline": {"main": "To Woo Drug Maker Shire, AbbVie Trod Cautiously in Tax Inversion Bid", "kicker": "DealBook", "content_kicker": null, "print_headline": "To Woo Shire, AbbVie Trod Cautiously in Takeover Bid", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 1, "major": "N"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": 2, "major": "N"}, {"name": "organizations", "value": "Abbott Laboratories", "rank": 3, "major": "N"}, {"name": "organizations", "value": "AbbVie Inc", "rank": 4, "major": "N"}, {"name": "organizations", "value": "AstraZeneca PLC", "rank": 5, "major": "N"}, {"name": "organizations", "value": "JPMorgan Chase & Company", "rank": 6, "major": "N"}, {"name": "organizations", "value": "Pfizer Inc", "rank": 7, "major": "N"}, {"name": "organizations", "value": "Shire PLC", "rank": 8, "major": "N"}], "pub_date": "2014-07-25T00:31:39+0000", "document_type": "article", "news_desk": "Business", "section_name": "Business Day", "byline": {"original": "By David Gelles", "person": [{"firstname": "David", "middlename": null, "lastname": "Gelles", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/cbf63f2d-f877-5c94-9bd6-9fd139d09c84", "word_count": 1129, "uri": "nyt://article/cbf63f2d-f877-5c94-9bd6-9fd139d09c84"}